Insight Molecular Diagnostics Inc. Operating Lease Cost
Insight Molecular Diagnostics Inc. (IMDX) reported Operating Lease Cost of $98.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. operating lease, cost for the quarter ending 2026-06-30 was $98.00K, a 25.19% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, cost for the quarter ending 2026-03-31 was $43.00K, a 68.84% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, cost for the quarter ending 2025-12-31 was $41.00K, a 70.92% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, cost for the quarter ending 2025-09-30 was $23.00K, a 86.31% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating lease, cost for fiscal 2025 was $333.00K, a 45.14% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. operating lease, cost for fiscal 2024 was $607.00K, a 27.91% decline from fiscal 2023.
- Insight Molecular Diagnostics Inc. operating lease, cost for fiscal 2023 was $842.00K.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 9 month as first filed | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98.00K 10-Q · filed 2026-08-10 | $141.00K 10-Q · filed 2026-08-10 | $182.00K derived: sum of 3 quarters · filed 2026-08-10 | $205.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $43.00K 10-Q · filed 2026-05-13 | $84.00K derived: sum of 2 quarters · filed 2026-05-13 | $107.00K derived: sum of 3 quarters · filed 2026-05-13 | $238.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $64.00K derived: sum of 2 quarters · filed 2026-03-26 | $195.00K derived: sum of 3 quarters · filed 2026-08-10 | $333.00K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $23.00K 10-Q · filed 2025-11-10 | $154.00K derived: sum of 2 quarters · filed 2026-08-10 | $292.00K 10-Q · filed 2025-11-10 | $433.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $131.00K 10-Q · filed 2026-08-10 | $269.00K 10-Q · filed 2026-08-10 | $410.00K derived: sum of 3 quarters · filed 2026-08-10 | $578.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-13 | $279.00K derived: sum of 2 quarters · filed 2026-05-13 | $447.00K derived: sum of 3 quarters · filed 2026-05-13 | $483.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $309.00K derived: sum of 2 quarters · filed 2026-03-26 | $345.00K derived: sum of 3 quarters · filed 2026-03-26 | $607.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $168.00K 10-Q · filed 2025-11-10 | $234.00K 10-Q · filed 2024-11-12 | $204.00K derived: sum of 2 quarters · filed 2025-11-10 | $466.00K 10-Q · filed 2025-11-10 | $532.00K 10-Q · filed 2024-11-12 | $502.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $36.00K 10-Q · filed 2025-08-11 | $128.00K 10-Q · filed 2025-08-11 | $334.00K derived: sum of 3 quarters · filed 2025-08-11 | $517.00K derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $92.00K 10-Q · filed 2025-05-12 | $298.00K derived: sum of 2 quarters · filed 2025-05-12 | $481.00K derived: sum of 3 quarters · filed 2025-05-12 | $671.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $389.00K derived: sum of 2 quarters · filed 2025-03-24 | $579.00K derived: sum of 3 quarters · filed 2025-03-24 | $842.00K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $183.00K 10-Q · filed 2024-11-12 | $373.00K derived: sum of 2 quarters · filed 2024-11-12 | $636.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $190.00K 10-Q · filed 2024-08-08 | $453.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |